Sputum smear-positive, Xpert ® MTB/RIF-negative results: magnitude and treatment outcomes of patients in Myanmar

This study is carried out in Yangon Region

• From: Foreign, Commonwealth & Development Office
• Published: 21 October 2019

• Country: Burma
• Document Type: Journal Article
• Theme: Health
• First published: 21 December 2018
• Authors: Phyu, M.H., Kyaw, K.W.Y., Myint, Z, Thida, A, Satyanarayana, S and Aung, S.T.

Abstract

Setting: Myanmar바카라 사이트™s National Tuberculosis Programme (NTP) uses the Xpert® MTB/RIF assay to diagnose rifampicin (RMP) resistance in sputum smear-positive (Sm+) pulmonary tuberculosis (TB) patients. The Xpert test may occasionally yield negative results (Xpert바카라 사이트“) for Mycobacterium tuberculosis complex, indicating a false-positive sputum smear result, false-negative Xpert result or infection with non-tuberculous mycobacteria (NTM). Patients with NTM may respond poorly to first-line anti-tuberculosis treatment.

Objective: To assess the burden of Sm+, Xpert바카라 사이트“ results at the national level and treatment outcomes of Sm+, Xpert바카라 사이트“ patients in Yangon Region.

This research was supported by the UK Department for International Development바카라 사이트™s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Phyu MH, Kyaw KWY, Myint Z, Thida A, Satyanarayana S, Aung ST. Sputum smear-positive, Xpert ® MTB/RIF-negative results: magnitude and treatment outcomes of patients in Myanmar. Public Health Action. 2018;8(4):181바카라 사이트“6.

Links

Published 21 October 2019